Concepts (189)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 13 | 2021 | 890 | 1.930 |
Why?
|
| Volatile Organic Compounds | 2 | 2023 | 10 | 0.910 |
Why?
|
| Fellowships and Scholarships | 1 | 2023 | 45 | 0.870 |
Why?
|
| Faculty, Nursing | 1 | 2023 | 60 | 0.840 |
Why?
|
| Stress, Psychological | 4 | 2019 | 254 | 0.800 |
Why?
|
| Parents | 3 | 2021 | 110 | 0.800 |
Why?
|
| Epidemics | 1 | 2021 | 4 | 0.760 |
Why?
|
| Electronic Nose | 2 | 2023 | 3 | 0.750 |
Why?
|
| Breath Tests | 2 | 2023 | 11 | 0.750 |
Why?
|
| Patient Care | 1 | 2021 | 34 | 0.740 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 115 | 0.740 |
Why?
|
| Nurse's Role | 2 | 2021 | 121 | 0.710 |
Why?
|
| Publications | 1 | 2020 | 16 | 0.700 |
Why?
|
| Biosensing Techniques | 1 | 2020 | 12 | 0.690 |
Why?
|
| Bayes Theorem | 1 | 2020 | 41 | 0.690 |
Why?
|
| Statistics as Topic | 1 | 2020 | 116 | 0.680 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 42 | 0.660 |
Why?
|
| Parenting | 1 | 2019 | 73 | 0.640 |
Why?
|
| Immunosenescence | 1 | 2018 | 4 | 0.620 |
Why?
|
| Fish Oils | 1 | 2018 | 5 | 0.620 |
Why?
|
| Caregivers | 1 | 2019 | 156 | 0.590 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2021 | 131 | 0.530 |
Why?
|
| Cytokines | 1 | 2018 | 351 | 0.530 |
Why?
|
| Humans | 35 | 2023 | 31070 | 0.520 |
Why?
|
| Inflammation | 1 | 2018 | 362 | 0.520 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 434 | 0.510 |
Why?
|
| HIV Wasting Syndrome | 2 | 2013 | 4 | 0.480 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 691 | 0.460 |
Why?
|
| Anticholesteremic Agents | 2 | 2011 | 20 | 0.430 |
Why?
|
| Complementary Therapies | 1 | 2012 | 10 | 0.400 |
Why?
|
| Fatty Alcohols | 1 | 2011 | 6 | 0.380 |
Why?
|
| Mannans | 2 | 2013 | 14 | 0.370 |
Why?
|
| Medically Underserved Area | 1 | 2011 | 15 | 0.370 |
Why?
|
| Dyslipidemias | 1 | 2011 | 23 | 0.370 |
Why?
|
| Obesity | 3 | 2013 | 307 | 0.370 |
Why?
|
| Education, Nursing, Graduate | 1 | 2012 | 95 | 0.360 |
Why?
|
| Weight Loss | 3 | 2013 | 117 | 0.360 |
Why?
|
| Double-Blind Method | 5 | 2018 | 499 | 0.310 |
Why?
|
| Dietary Supplements | 5 | 2018 | 63 | 0.300 |
Why?
|
| Anesthesia | 2 | 2021 | 36 | 0.300 |
Why?
|
| Hyperlipidemias | 2 | 2004 | 22 | 0.290 |
Why?
|
| Anesthesia, General | 2 | 2019 | 30 | 0.280 |
Why?
|
| Anti-Obesity Agents | 1 | 2005 | 5 | 0.260 |
Why?
|
| Dietary Fiber | 1 | 2005 | 23 | 0.260 |
Why?
|
| Body Weight | 1 | 2005 | 141 | 0.250 |
Why?
|
| Female | 15 | 2023 | 17018 | 0.240 |
Why?
|
| Lipids | 1 | 2004 | 38 | 0.240 |
Why?
|
| Enteral Nutrition | 2 | 2004 | 56 | 0.240 |
Why?
|
| Insulin Resistance | 1 | 2004 | 60 | 0.230 |
Why?
|
| Middle Aged | 9 | 2019 | 10239 | 0.230 |
Why?
|
| Child, Preschool | 3 | 2021 | 691 | 0.220 |
Why?
|
| Nonlinear Dynamics | 1 | 2023 | 15 | 0.220 |
Why?
|
| Monitoring, Physiologic | 1 | 2004 | 95 | 0.220 |
Why?
|
| Adult | 11 | 2019 | 8949 | 0.220 |
Why?
|
| Male | 12 | 2019 | 16499 | 0.210 |
Why?
|
| United States | 4 | 2019 | 2375 | 0.210 |
Why?
|
| Hospitalization | 2 | 2016 | 336 | 0.210 |
Why?
|
| Arginine | 1 | 2002 | 19 | 0.210 |
Why?
|
| Immunity | 1 | 2002 | 26 | 0.210 |
Why?
|
| Advance Care Planning | 1 | 2022 | 17 | 0.200 |
Why?
|
| Sensitivity and Specificity | 2 | 2023 | 586 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2002 | 93 | 0.200 |
Why?
|
| Racism | 1 | 2022 | 36 | 0.200 |
Why?
|
| Nursing Services | 1 | 2021 | 1 | 0.190 |
Why?
|
| Adolescent | 4 | 2019 | 2403 | 0.190 |
Why?
|
| Child | 3 | 2021 | 1431 | 0.190 |
Why?
|
| Nursing Research | 1 | 2021 | 38 | 0.180 |
Why?
|
| Patient Satisfaction | 2 | 2014 | 310 | 0.180 |
Why?
|
| Health Literacy | 1 | 2022 | 108 | 0.180 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 199 | 0.180 |
Why?
|
| Exercise | 3 | 2021 | 505 | 0.180 |
Why?
|
| Organizational Innovation | 1 | 2020 | 21 | 0.180 |
Why?
|
| Exhalation | 1 | 2020 | 3 | 0.180 |
Why?
|
| Physical Fitness | 1 | 2020 | 60 | 0.170 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 30 | 0.170 |
Why?
|
| Cholesterol, LDL | 3 | 2011 | 33 | 0.170 |
Why?
|
| Triglycerides | 3 | 2011 | 47 | 0.170 |
Why?
|
| Decision Making | 1 | 2021 | 237 | 0.160 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2018 | 18 | 0.160 |
Why?
|
| Midwestern United States | 1 | 2018 | 70 | 0.150 |
Why?
|
| Quality of Life | 3 | 2022 | 696 | 0.150 |
Why?
|
| Police | 1 | 2016 | 4 | 0.140 |
Why?
|
| Prisoners | 1 | 2016 | 10 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1008 | 0.130 |
Why?
|
| Depression | 1 | 2020 | 481 | 0.130 |
Why?
|
| Cognition | 2 | 2021 | 1427 | 0.120 |
Why?
|
| Biomarkers | 1 | 2018 | 733 | 0.120 |
Why?
|
| Treatment Failure | 2 | 2013 | 168 | 0.120 |
Why?
|
| Perioperative Nursing | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cathartics | 1 | 2013 | 4 | 0.120 |
Why?
|
| Military Personnel | 1 | 2014 | 31 | 0.110 |
Why?
|
| Nurse-Patient Relations | 1 | 2014 | 39 | 0.110 |
Why?
|
| Prevalence | 2 | 2013 | 500 | 0.110 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 42 | 0.110 |
Why?
|
| Mindfulness | 1 | 2014 | 34 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 71 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2014 | 135 | 0.110 |
Why?
|
| Cognition Disorders | 1 | 2019 | 1055 | 0.100 |
Why?
|
| Body Composition | 3 | 2013 | 67 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2011 | 72 | 0.090 |
Why?
|
| Pilot Projects | 3 | 2017 | 429 | 0.090 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2009 | 2 | 0.080 |
Why?
|
| Treatment Outcome | 6 | 2009 | 3809 | 0.070 |
Why?
|
| Cholesterol | 2 | 2004 | 55 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1133 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 1 | 2004 | 19 | 0.060 |
Why?
|
| Fasting | 1 | 2004 | 13 | 0.060 |
Why?
|
| Sample Size | 1 | 2004 | 25 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 443 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2004 | 6 | 0.060 |
Why?
|
| Equipment Failure | 1 | 2004 | 53 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 331 | 0.060 |
Why?
|
| Insulin | 1 | 2004 | 97 | 0.060 |
Why?
|
| Hot Flashes | 1 | 2003 | 16 | 0.060 |
Why?
|
| Plant Preparations | 1 | 2003 | 9 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2004 | 120 | 0.060 |
Why?
|
| Phytotherapy | 1 | 2003 | 14 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2004 | 108 | 0.060 |
Why?
|
| Social Problems | 1 | 2023 | 5 | 0.060 |
Why?
|
| Adaptation, Psychological | 2 | 2020 | 147 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2004 | 144 | 0.050 |
Why?
|
| Food Technology | 1 | 2002 | 1 | 0.050 |
Why?
|
| Food, Genetically Modified | 1 | 2002 | 1 | 0.050 |
Why?
|
| Low Back Pain | 1 | 2004 | 144 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 98 | 0.050 |
Why?
|
| Placebos | 1 | 2002 | 79 | 0.050 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 49 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 489 | 0.050 |
Why?
|
| Food, Formulated | 1 | 2002 | 6 | 0.050 |
Why?
|
| Disease Progression | 3 | 2014 | 830 | 0.050 |
Why?
|
| HIV | 1 | 2002 | 83 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2022 | 74 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2002 | 162 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 95 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 344 | 0.050 |
Why?
|
| Grounded Theory | 1 | 2021 | 5 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 86 | 0.050 |
Why?
|
| Health Personnel | 1 | 2022 | 118 | 0.050 |
Why?
|
| Biological Products | 1 | 2002 | 46 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2021 | 118 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 10079 | 0.050 |
Why?
|
| Self Report | 1 | 2021 | 231 | 0.040 |
Why?
|
| Nurse Anesthetists | 1 | 2019 | 3 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 453 | 0.040 |
Why?
|
| Mothers | 1 | 2021 | 184 | 0.040 |
Why?
|
| Dementia | 1 | 2004 | 560 | 0.040 |
Why?
|
| Infant | 1 | 2019 | 578 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 35 | 0.040 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2017 | 15 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1505 | 0.040 |
Why?
|
| Prisons | 1 | 2016 | 11 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 223 | 0.030 |
Why?
|
| Animals | 1 | 2005 | 4724 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 244 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 551 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 8 | 0.030 |
Why?
|
| Hospitals, Military | 1 | 2014 | 2 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 40 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 38 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 40 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 117 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 208 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 128 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 145 | 0.030 |
Why?
|
| Communication | 1 | 2014 | 120 | 0.030 |
Why?
|
| Safety | 2 | 2002 | 50 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2009 | 11 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 1681 | 0.020 |
Why?
|
| Morbidity | 1 | 2009 | 65 | 0.020 |
Why?
|
| Energy Intake | 1 | 2009 | 73 | 0.020 |
Why?
|
| Evidence-Based Practice | 1 | 2009 | 77 | 0.020 |
Why?
|
| Metabolic Syndrome | 1 | 2009 | 68 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 1209 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 226 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 2063 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 2004 | 17 | 0.020 |
Why?
|
| Cimicifuga | 1 | 2003 | 1 | 0.010 |
Why?
|
| Soy Foods | 1 | 2003 | 1 | 0.010 |
Why?
|
| Phytoestrogens | 1 | 2003 | 3 | 0.010 |
Why?
|
| Angelica sinensis | 1 | 2003 | 5 | 0.010 |
Why?
|
| Isoflavones | 1 | 2003 | 4 | 0.010 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2003 | 19 | 0.010 |
Why?
|
| Vitamin E | 1 | 2003 | 29 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2003 | 161 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 2002 | 26 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2002 | 25 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2002 | 145 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2002 | 143 | 0.010 |
Why?
|
| Viral Load | 1 | 2002 | 196 | 0.010 |
Why?
|